EHA 2016: Professor Hallek on the Unmet Needs ... - CLL Support

CLL Support

23,335 members40,040 posts

EHA 2016: Professor Hallek on the Unmet Needs in CLL

bkoffman profile image
bkoffmanCLL CURE Hero
6 Replies

Today in the 2016 Conference Coverage section of the CLL Society website, we’ve posted an interview with Dr. Michael Hallek about the unmet needs in CLL as well as his approach to addressing them through research. You can view my interview here. cllsociety.org/2016/10/eha-...

It is a very thoughtful discussion and focuses on the need for combination therapies.

If you have not yet participated in our Reader Poll to give us feedback about how we’re doing and what topics you would like to see covered in the future, please take 2 minutes and do so if you have time. We appreciate the input we’ve received so far and would love to receive more. Thank you. You can access it here. q32016ask.questionpro.com/

Stay strong.

We are all in this together.

Brian Koffman

cllsociety.org

bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
6 Replies
wroxham-gb profile image
wroxham-gb

Good interview, worth watching.

Have completed your poll.

Sue

GB

DanaM profile image
DanaM

Thank You Brian for doing this interview :)

splashsplash profile image
splashsplash

Really informative interview, thanks Brian. Is there any way that after the trials are completed in the next 12 months, the results can be made known to the CLL community?

ikahan profile image
ikahan

Excellent talk , thank you Brian

mnmnewtons profile image
mnmnewtons

After viewing the above interview, I also watched the EHA 2016 interview you had with Dr. Jeff Jones regarding combination therapies in CLL. One of the listed "takeaways" was the assertion that adding Rituxan to TKI inhibitors, like Ibrutinab or Idelalisib, do not clearly improve outcomes. Since neither that, nor the video, referenced any studies to support Dr. Jones' statement, are you aware of any such studies. It is my understanding that Idelalisib with Rituxan is routinely used in combination in the clinical setting, as it is supported by clinical trials an studies. For context, I have posted on Health Unlocked. I have del17p, TP53 mutation and unmutated IgHV. i am now on Idelalisib (150mg b.i.d. and have had 4 weekly and 7 monthy infusions of Rituxan at 900mg.

Malcolm

bkoffman profile image
bkoffmanCLL CURE Hero in reply tomnmnewtons

Adding rituximab speeds up the response but it is unclear that it deepens or prolongs it. This is based on the the less than perfect science of comparing one trial to another. The story may be quite different with add rituximab to venetoclax.

Not what you're looking for?

You may also like...

ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL

We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize...
bkoffman profile image
CLL CURE Hero

Dr. Kanti Rai on the Future of CLL Therapy

Friends, This week we have posted an interview with one and only Dr. Kanti Rai when he sat down to...
bkoffman profile image
CLL CURE Hero

Prevalence and Economic Burden of Chronic Lymphocytic Leukemia (CLL) in the Era of Oral Targeted Therapies

This has been a banner year for developments in the treatment of CLL. In this last week of 2015 on...
bkoffman profile image
CLL CURE Hero

How Ibrutinib works over time

Hi, At ASH 2016 in San Diego, CA, I had the honor of once again interviewing Dr. Wiestner from the...
bkoffman profile image
CLL CURE Hero

CLL Society' s abstract on what we want in our disease management published today in the ASH CLL abstracts.

Hi, I am so excited. If you haven’t already, please check out our ASH abstract,....
bkoffman profile image
CLL CURE Hero

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
AussieNeil profile image
AussieNeilAdministrator
CLLerinOz profile image
CLLerinOzAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.